Literature DB >> 19741523

Neutropenia in type Ib glycogen storage disease.

Janice Y Chou1, Hyun S Jun, Brian C Mansfield.   

Abstract

PURPOSE OF REVIEW: Glycogen storage disease type Ib, characterized by disturbed glucose homeostasis, neutropenia, and neutrophil dysfunction, is caused by a deficiency in a ubiquitously expressed glucose-6-phosphate transporter (G6PT). G6PT translocates glucose-6-phosphate (G6P) from the cytoplasm into the lumen of the endoplasmic reticulum, in which it is hydrolyzed to glucose either by a liver/kidney/intestine-restricted glucose-6-phosphatase-alpha (G6Pase-alpha) or by a ubiquitously expressed G6Pase-beta. The role of the G6PT/G6Pase-alpha complex is well established and readily explains why G6PT disruptions disturb interprandial blood glucose homeostasis. However, the basis for neutropenia and neutrophil dysfunction in glycogen storage disease type Ib is poorly understood. Recent studies that are now starting to unveil the mechanisms are presented in this review. RECENT
FINDINGS: Characterization of G6Pase-beta and generation of mice lacking either G6PT or G6Pase-beta have shown that neutrophils express the G6PT/G6Pase-beta complex capable of producing endogenous glucose. Loss of G6PT activity leads to enhanced endoplasmic reticulum stress, oxidative stress, and apoptosis that underlie neutropenia and neutrophil dysfunction in glycogen storage disease type Ib.
SUMMARY: Neutrophil function is intimately linked to the regulation of glucose and G6P metabolism by the G6PT/G6Pase-beta complex. Understanding the molecular mechanisms that govern energy homeostasis in neutrophils has revealed a previously unrecognized pathway of intracellular G6P metabolism in neutrophils.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19741523      PMCID: PMC3099242          DOI: 10.1097/MOH.0b013e328331df85

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  76 in total

Review 1.  The endoplasmic reticulum and the unfolded protein response.

Authors:  Jyoti D Malhotra; Randal J Kaufman
Journal:  Semin Cell Dev Biol       Date:  2007-09-08       Impact factor: 7.727

2.  Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.

Authors:  W H Yiu; C-J Pan; M Allamarvdasht; S Y Kim; J Y Chou
Journal:  Gene Ther       Date:  2006-09-28       Impact factor: 5.250

Review 3.  Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.

Authors:  Janice Yang Chou; Dietrich Matern; Brian C Mansfield; Yuan-Tsong Chen
Journal:  Curr Mol Med       Date:  2002-03       Impact factor: 2.222

4.  Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib.

Authors:  I Gerin; M Veiga-da-Cunha; Y Achouri; J F Collet; E Van Schaftingen
Journal:  FEBS Lett       Date:  1997-12-15       Impact factor: 4.124

5.  Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.

Authors:  Jean Donadieu; Thierry Leblanc; Brigitte Bader Meunier; Mohamed Barkaoui; Odile Fenneteau; Yves Bertrand; Micheline Maier-Redelsperger; Marguerite Micheau; Jean Louis Stephan; Noel Phillipe; Pierre Bordigoni; Annie Babin-Boilletot; Philippe Bensaid; Anne Marie Manel; Etienne Vilmer; Isabelle Thuret; Stephane Blanche; Eliane Gluckman; Alain Fischer; Françoise Mechinaud; Bertrand Joly; Thierry Lamy; Olivier Hermine; Bruno Cassinat; Christine Bellanné-Chantelot; Christine Chomienne
Journal:  Haematologica       Date:  2005-01       Impact factor: 9.941

6.  Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse.

Authors:  K J Lei; H Chen; C J Pan; J M Ward; B Mosinger; E J Lee; H Westphal; B C Mansfield; J Y Chou
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

7.  The catalytic center of glucose-6-phosphatase. HIS176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis.

Authors:  Abhijit Ghosh; Jeng-Jer Shieh; Chi-Jiunn Pan; Mao-Sen Sun; Janice Yang Chou
Journal:  J Biol Chem       Date:  2002-07-01       Impact factor: 5.157

8.  The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.

Authors:  Philip S Rosenberg; Blanche P Alter; Audrey A Bolyard; Mary Ann Bonilla; Laurence A Boxer; Bonnie Cham; Carol Fier; Melvin Freedman; George Kannourakis; Sally Kinsey; Beate Schwinzer; Connie Zeidler; Karl Welte; David C Dale
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

9.  Functional analysis of mutations in the glucose-6-phosphate transporter that cause glycogen storage disease type Ib.

Authors:  Shih-Yin Chen; Chi-Jiunn Pan; Soojung Lee; Wentao Peng; Janice Y Chou
Journal:  Mol Genet Metab       Date:  2008-10-02       Impact factor: 4.797

Review 10.  The mammalian unfolded protein response.

Authors:  Martin Schröder; Randal J Kaufman
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

View more
  29 in total

Review 1.  Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Nat Rev Endocrinol       Date:  2010-10-26       Impact factor: 43.330

2.  Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib.

Authors:  Hyun Sik Jun; David A Weinstein; Young Mok Lee; Brian C Mansfield; Janice Y Chou
Journal:  Blood       Date:  2014-02-24       Impact factor: 22.113

3.  Hepatomegaly with neutropenia: a girl with glycogen storage disease Ib.

Authors:  Deepanjan Bhattacharya; Anil Kumar Bn; Inusha Panigrahi; Anupriya Kaur
Journal:  BMJ Case Rep       Date:  2019-07-18

4.  Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function.

Authors:  Daniela Melis; Fortunata Carbone; Giorgia Minopoli; Claudia La Rocca; Francesco Perna; Veronica De Rosa; Mario Galgani; Generoso Andria; Giancarlo Parenti; Giuseppe Matarese
Journal:  J Immunol       Date:  2017-04-07       Impact factor: 5.422

5.  Glucose-6-phosphatase-β, implicated in a congenital neutropenia syndrome, is essential for macrophage energy homeostasis and functionality.

Authors:  Hyun Sik Jun; Yuk Yin Cheung; Young Mok Lee; Brian C Mansfield; Janice Y Chou
Journal:  Blood       Date:  2012-01-12       Impact factor: 22.113

6.  Survival, but not maturation, is affected in neutrophil progenitors from GSD-1b patients.

Authors:  Gepke Visser; Wilco de Jager; Liesbeth P Verhagen; G Peter A Smit; Frits A Wijburg; Berent J Prakken; Paul J Coffer; Miranda Buitenhuis
Journal:  J Inherit Metab Dis       Date:  2011-08-24       Impact factor: 4.982

7.  Vitamin E Improves Clinical Outcome of Patients Affected by Glycogen Storage Disease Type Ib.

Authors:  Daniela Melis; Giorgia Minopoli; Francesca Balivo; Paola Marcolongo; Rossella Parini; Sabrina Paci; Carlo Dionisi-Vici; Roberto Della Casa; Angelo Benedetti; Generoso Andria; Giancarlo Parenti
Journal:  JIMD Rep       Date:  2015-06-30

Review 8.  Molecular biology and gene therapy for glycogen storage disease type Ib.

Authors:  Janice Y Chou; Jun-Ho Cho; Goo-Young Kim; Brian C Mansfield
Journal:  J Inherit Metab Dis       Date:  2018-04-16       Impact factor: 4.982

Review 9.  The SLC37 family of sugar-phosphate/phosphate exchangers.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

Review 10.  The SLC37 family of phosphate-linked sugar phosphate antiporters.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.